Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment

Completed

Conditions studied: Autism Spectrum Disorders, Psychosis, Fragile X Syndrome

In brief

The purpose of the proposed research is to study the potential changes in biomarkers of patients with neurodevelopmental disorders in response to treatment in clinical trials or in private psychiatry practice utilizing non-invasive psychophysiological measurements. The investigators plan to obtain psychophysical measurements throughout several periods of treatment.

Key facts

Study ID

NCT01364818

Run by

University of North Carolina, Chapel Hill

People needed

25

Starts

2011-09-01

Expected to finish

2014-12-01

Last updated by the study team

2016-04-18

Who can join

Age: 3 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are eligible to participate in a clinical trial conducted by Dr. Sikich or individuals who have initiated/changed pharmacologic treatment (as private patient of a study physician)
• Diagnosis of autism spectrum disorder (ASD), psychotic spectrum disorder (PSD), or Fragile X syndrome.
• Ages 3-45 inclusive

You may not qualify if…

• Non-English Speaking subject or parent/guardian

Where it is running

• University of North Carolina Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.